Acyclovir
- Product NDC
- 50090-7277
- 11-digit product format
- 500907277
- Labeler code
- 50090
- Product ID
- 50090-7277_977ae4c5-6edd-42f5-b521-a40b0bdb3660
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Acyclovir
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA210401
- Marketing category
- ANDA
- Marketing start
- 2023-06-20
- Substance
- ACYCLOVIR
- Active strength
- 400 mg/1
- Pharmacologic classes
- DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| X4HES1O11F | ACYCLOVIR | 59277-89-3 | ACYCLOVIR |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 50090-7277-0 | 50090727700 | 90 TABLET in 1 BOTTLE (50090-7277-0) | 90 tablet | 2024-10-08 | No | No | Historical |